Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases

Stroke

Volumn 31, Issue 11, 2000, Pages 2648-2652

  Kramer, Judit ^a   Harcos, Péter ^b   Prohászka, Zoltán ^c   Horváth, Laura ^c   Karádi, István ^c   Singh, Mahavir ^d   Császár, Albert ^c   Romics, László ^c   Füst, George ^c  

^a ST JOHN'S HOSPITAL   (Hungary)

^b Szent Imre Hospital   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Cerebrovascular disorders; Genetics; Heat shock proteins; Stroke

Indexed keywords

AUTOANTIBODY; COMPLEMENT; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPLEMENT SYSTEM; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0033766746     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.11.2648     Document Type: Article

References (31)

1. Relationship between arterial disease in different sites: A study of the aorta and coronary, carotid and iliac arteries
2. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case-control study
3. Ultrasonic evaluation of early carotid atherosclerosis
4. Intermittent claudication, heart disease, risk factors and mortality: The Whitehall Study
5. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound
6. Potential of carotid ultrasonography in the diagnosis of coronary artery disease
7. The natural history of asymptomatic carotid artery occlusive lesions
8. Epidemiology of stroke
9. C4B*Q0 allotype as risk factor for myocardial infarction
10. Increased frequency of C4B null alleles in Icelandic patients with coronary disease
11. Atherosclerosis: An inflammatory disease
12. Vulnerable plaque: Pathobiology and clinical implications
13. Is atherosclerosis an immunologically mediated disease?
14. Association between antibodies to heat shock protein 65 and coronary atherosclerosis: Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk
15. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction
16. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: Clinical significance determined in a follow-up study
17. Classification and natural history of clinically identifiable subtypes of cerebral infarction
18. A marked drop in the incidence of the null allel of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival
19. Inherited structural polymorphism of human complement
20. Phenotyping of human complement component C4
21. High voltage agarose electrophoresis in the study of C3 polymorphism
22. Antibodies against human hsp60 and mycobacterial hsp65 differ in their antigen specificity and complement activating ability
23. Differences in C4B allele frequencies between patients with cerebrovascular and coronary heart disease
24. Family history in patients with transient ischemic attacks
25. Genetic epidemiology and family studies of stroke
26. Association of antibodies to heat-shock protein 65 with percutaneous transluminal coronary angioplasty and subsequent restenosis
27. The role of heat shock proteins in protection and pathophysiology of the arterial wall
28. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis
29. Processes in atherogenesis: Complement activation
30. Immunohistochemical demonstration of enzymatically modified human LDL and its co-localization with the terminal complement complex in early atherosclerotic lesion
31. Antibodies against cholesterol (ACHA) in patients with different vascular diseases and healthy individuals: Characterization of human ACHA